Overview

Neurobehavioral Mechanisms of Choice in Opioid Use Disorder

Status:
Recruiting
Trial end date:
2023-06-30
Target enrollment:
Participant gender:
Summary
The objective of this protocol is to use probabilistic reinforcement learning choice tasks and magnetic resonance neuroimaging to demonstrate the impact of problematic opioid use and opioid withdrawal on dynamic decision-making and reveal the neurobehavioral and neurobiological processes underlying abnormal task performance. A second objective is to identify an appropriate dose of intravenous remifentanil for subsequent studies in physically dependent individuals with opioid use disorder.
Phase:
Early Phase 1
Details
Lead Sponsor:
Joshua A. Lile, Ph.D.
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Oxycodone
Remifentanil